To access this element change to forms mode OFF
Grant Award View - GA83513
Circulating tumour DNA guidEd Therapy for stage IIB/C BRAF mutant...
GA ID:
GA83513
Agency:
Department of Health and Aged Care
Approval Date:
4-May-2020
Publish Date:
15-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2025
Value (AUD):
$3,230,670.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 1.1 Health Policy Research and Analysis
Grant Program:
2019_MRFF International Clinical Trials_PRC3_funding_ commencing_2020
Grant Activity:
Circulating tumour DNA guidEd Therapy for stage IIB/C BRAF mutant positive mElanoma after surgiCal resecTION (DETECTION)
Purpose:
DETECTION is a phase III, international trial that will enrol 1050 patients with stage IIB/C melanoma. It will examine whether a blood test containing tumour DNA (ctDNA) will be able to identify patients at high risk of recurrence following their curative surgery even though their scans appear normal. It will also evaluate if treating these patients early with immunotherapy based on the ctDNA positive result will improve overall survival.
GO ID:
GO Title:
Medical Research Future Fund – International Clinical Trial Collaborations Grant Opportunity
Internal Reference ID:
MRF1192497
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, WA, QLD, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED KINGDOM